What is the likely explanation for the fluctuating serum calcium and intact parathyroid hormone levels in this female patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Fluctuating Calcium and PTH: Laboratory Artifact or Assay Interference

This patient most likely has laboratory assay interference causing spurious PTH measurements, with the most probable diagnosis being either macro-PTH or PTH assay variability between different measurement platforms. 1

Understanding the Pattern

The calcium and PTH values show no consistent physiologic relationship:

  • When calcium is 10.4, PTH is 22 (appropriate)
  • When calcium drops to 9.6, PTH rises to 25 (appropriate response)
  • But then calcium jumps to 10.9 with PTH dropping to 10 (inverse of expected)
  • Then calcium 9.6 with PTH 16 (inconsistent)
  • Finally calcium 10.4 with PTH 31 (elevated)

This erratic, non-physiologic pattern strongly suggests measurement artifact rather than true parathyroid disease.

Primary Differential: Assay Interference

PTH Assay Variability

PTH immunoassays use different antibodies and recognize not only biologically active full-length PTH but also PTH fragments, leading to remarkable differences between laboratories even when measuring the same sample 1. The lack of standardization across PTH assays is well-documented and can produce exactly this type of fluctuating, inconsistent pattern.

Macro-PTH

Macro-PTH represents PTH bound to immunoglobulins that creates falsely elevated readings 2. A recent 2025 case demonstrated PTH levels >1200 pg/mL that dropped to ~40 pg/mL (97% reduction) after polyethylene glycol (PEG) 6000 precipitation, confirming macro-PTH interference 2. This patient had normal calcium, phosphate, and vitamin D—similar to your patient's inconsistent pattern.

What to Do Next

1. Verify Sample Handling and Timing

  • Ensure all samples were drawn fasting
  • Confirm calcium and PTH measured on same sample simultaneously 3
  • Check if different laboratories or assay platforms were used

2. Measure Ionized Calcium

Ionized calcium is particularly useful in intermediate or doubtful situations when total calcium is in the upper normal range or only moderately increased 3. This eliminates albumin-binding artifacts.

3. Test for Macro-PTH

Perform PEG 6000 precipitation assay on a sample with elevated PTH 2. A reduction >90% indicates macro-PTH interference, while reductions of 65-72% are seen with true hyperparathyroidism.

4. Calculate Fractional Excretion of Calcium (FeCa)

FeCa >2% indicates primary hyperparathyroidism and provides better discrimination than 24-hour urine calcium alone 3. This helps differentiate true parathyroid disease from artifact.

5. Check Vitamin D Status

Measure 25(OH)vitamin D, as insufficiency is a frequent cause of secondary hyperparathyroidism that could confound interpretation 3. Vitamin D should be normalized for at least 6 months before accepting a diagnosis of normocalcemic primary hyperparathyroidism.

Alternative Considerations

If True Primary Hyperparathyroidism

Some patients with hyperparathyroidism demonstrate "disappearing hypercalcemia" with spontaneous normalization of calcium despite elevated PTH 4. However, this typically shows a consistent pattern of elevated PTH, not the erratic fluctuations seen here.

Inappropriate Normal PTH

Primary hyperparathyroidism can present with PTH in the "normal" laboratory range that is actually inappropriate for the degree of hypercalcemia 3, 5. However, your patient's PTH of 10 when calcium was 10.9 would be appropriately suppressed, not inappropriately normal.

Critical Pitfalls to Avoid

  • Don't pursue parathyroid imaging until you've confirmed the biochemical diagnosis is real and reproducible
  • Don't assume different "normal" values mean the patient is normal—PTH reference ranges vary dramatically between assays 1
  • Don't diagnose primary hyperparathyroidism based on a single set of labs when the pattern is physiologically inconsistent
  • Don't overlook assay interference as the most common cause of bizarre, non-physiologic lab patterns

Bottom Line

Repeat all measurements on the same day, same sample, using the same laboratory platform, and test for macro-PTH interference 1, 2. The erratic, non-physiologic relationship between calcium and PTH strongly favors laboratory artifact over true parathyroid disease. Only after excluding assay interference should you consider atypical presentations of hyperparathyroidism.

References

3
Guideline

chapter 2: primary hyperparathyroidism: diagnosis.

Annales d'endocrinologie, 2025

4
Research

Disappearing hypercalcaemia.

Postgraduate medical journal, 1987

Related Questions

At what Parathyroid Hormone (PTH) level should I be concerned about hyperparathyroidism?
After how many hours does calcium‑phosphate antacid (Celphos) typically cause fatal outcomes following ingestion?
In a bariatric patient with elevated intact parathyroid hormone, normal serum calcium, normal renal function, and a low‑normal vitamin D level (35–40 ng/mL), what explains the elevated PTH?
Does hypercalcemia with an elevated intact PTH level and impaired renal function suggest primary hyperparathyroidism?
What is the appropriate management for a patient with stage 5 CKD, secondary hyperparathyroidism, hyperphosphatemia, hypocalcemia, and bone pain?
Can a transient ischemic attack cause outward foot positioning?
For a hospice patient who has experienced a transient ischemic attack with weakness, pain, or abnormal foot positioning, what is the appropriate management regarding stroke prevention and symptom control?
What underlying medical conditions can cause persistent short‑hair frizz that does not improve with argan oil or other cosmetic moisturizers?
How does progesterone affect bone density in postmenopausal women?
A patient is taking zofenopril 7.5 mg and lercanidipine 20 mg; which Tripliam (perindopril/amlodipine) formulation should be prescribed?
Which selective serotonin reuptake inhibitor (SSRI) is most sedating and helpful for sleep?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.